Literature DB >> 21920241

Melasma: a comprehensive update: part I.

Vaneeta M Sheth1, Amit G Pandya2.   

Abstract

Melasma is a common disorder of hyperpigmentation affecting millions of people worldwide. While it is thought to be triggered or exacerbated by sun exposure and hormones, much remains to be understood about its pathogenesis. A thorough understanding of the etiology of melasma and the research tools available to study this condition are crucial to enhancing management and developing novel targeted therapies of this often frustrating condition.
Copyright © 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21920241     DOI: 10.1016/j.jaad.2010.12.046

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  39 in total

1.  Melasma and laser treatment: an evidenced-based analysis.

Authors:  Shlomit Halachmi; Merete Haedersdal; Moshe Lapidoth
Journal:  Lasers Med Sci       Date:  2013-06-14       Impact factor: 3.161

Review 2.  [Melasma : An update on the clinical picture, treatment, and prevention].

Authors:  S Becker; C Schiekofer; T Vogt; J Reichrath
Journal:  Hautarzt       Date:  2017-02       Impact factor: 0.751

3.  The effect of melasma on self-esteem: A pilot study.

Authors:  J Jiang; O Akinseye; A Tovar-Garza; A G Pandya
Journal:  Int J Womens Dermatol       Date:  2017-12-08

4.  The Effect of Melasma on the Quality of Life in a Sample of Women Living in Singapore.

Authors:  Ochi Harumi; Chee Leok Goh
Journal:  J Clin Aesthet Dermatol       Date:  2016-01

5.  Intradermal Tranexamic Acid Injection for the Treatment of Melasma: A Pilot Study with 48-week Follow-up.

Authors:  Suparuj Lueangarun; Punyaphat Sirithanabadeekul; Prapalpitch Wongwicharn; Chutimon Namboonlue; Sarun Pacharapakornpong; Premjit Juntongjin; Therdpong Tempark
Journal:  J Clin Aesthet Dermatol       Date:  2020-08-01

6.  Biodegradable Kojic Acid-Based Polymers: Controlled Delivery of Bioactives for Melanogenesis Inhibition.

Authors:  Jonathan J Faig; Alysha Moretti; Laurie B Joseph; Yingyue Zhang; Mary Joy Nova; Kervin Smith; Kathryn E Uhrich
Journal:  Biomacromolecules       Date:  2017-01-26       Impact factor: 6.988

Review 7.  Melasma in Men: A Review of Clinical, Etiological, and Management Issues.

Authors:  Rashmi Sarkar; Pallavi Ailawadi; Shilpa Garg
Journal:  J Clin Aesthet Dermatol       Date:  2018-02-01

8.  Melasma and low-energy Q-switched laser: treatment assessment by means of in vivo confocal microscopy.

Authors:  Caterina Longo; Giovanni Pellacani; Athanasia Tourlaki; Michela Galimberti; Pier Luca Bencini
Journal:  Lasers Med Sci       Date:  2013-11-30       Impact factor: 3.161

9.  Efficacy and safety of fractional Q-switched 1064-nm neodymium-doped yttrium aluminum garnet laser in the treatment of melasma in Chinese patients.

Authors:  Baishuang Yue; Qianli Yang; Jinhua Xu; Zhong Lu
Journal:  Lasers Med Sci       Date:  2016-07-23       Impact factor: 3.161

Review 10.  Confetti-like Sparing: A Diagnostic Clinical Feature of Melasma.

Authors:  Douglas C Wu; Richard E Fitzpatrick; Mitchel P Goldman
Journal:  J Clin Aesthet Dermatol       Date:  2016-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.